Drug Shortage Report for TEVA-AMLODIPINE

Last updated on 2020-07-10 History
Report ID 114442
Drug Identification Number 02250500
Brand name TEVA-AMLODIPINE
Common or Proper name AMLODIPINE 10MG TAB
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) AMLODIPINE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 250
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-07
Estimated end date
Actual end date 2020-05-13
Shortage status Resolved
Updated date 2020-07-10
Company comments Item is discontinued.
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-07-10 French Compare
v3 2020-07-10 English Compare
v2 2020-05-08 French Compare
v1 2020-05-08 English Compare

Showing 1 to 4 of 4